Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study

被引:55
作者
Hansson, Jonas [1 ]
Lind, Lars [1 ]
Hulthe, Johannes [2 ]
Sundstrom, Johan [1 ]
机构
[1] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden
[2] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2009年 / 16卷 / 03期
基金
瑞典研究理事会;
关键词
congestive; epidemiology; extracellular matrix; heart failure; left ventricular hypertrophy; population; MATRIX-METALLOPROTEINASE INHIBITION; CONGESTIVE-HEART-FAILURE; DILATED CARDIOMYOPATHY; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; UP-REGULATION; MATRIX-METALLOPROTEINASE-9; HYPERTROPHY; ANGIOGENESIS; DEGRADATION;
D O I
10.1097/HJR.0b013e3283213108
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Extracellular matrix remodeling is a hallmark of pathological left ventricular (LV) hypertrophy and heart failure. This process is tightly controlled by the degrading matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). We hypothesized that circulating MMP-9 and TIMP-1 levels are altered already in persons with the signs of LV remodeling that forego clinical heart failure. Design Cross-sectional study in the Prospective Investigation of the Vasculature in Uppsala Seniors, a community-based cohort of 891 70-year-old men and women free from valvular disease, heart failure, and myocardial infarction. Methods We examined relations of serum MMP-9 and TIMP-1 to echocardiographic LV geometry and function. All models were adjusted for sex, height, intra-arterial systolic and diastolic blood pressures, anti hypertensive medication use, and serum freezer time. Results Serum TIMP-1 was positively related to LV mass and wall thickness (r=0.15, P<0.0001 and r=0.16, P<0.0001, respectively), with a 32 g higher LV mass and 2.2 mm thicker walls in the fourth compared with the first quartile of serum TIMP-1. Serum TIMP-1 was also inversely related to LV ejection fraction (r=-0.10, P=0.009), but not to LV dimension or diastolic function indices. Serum MMP-9 was only weakly related to LV wall thickness and isovolumic relaxation time (r=0.08, P=0.04 and r=-0.08, P=0.04). Conclusion In this large population-based sample, serum TIMP-1 levels were related to LV mass, wall thickness, and inversely to systolic function. This may imply that extracellular matrix remodeling is involved already in the earliest stages of the process leading to heart failure. Eur J Cardiovasc Prev Rehabil 16:297-303 (C) 2009 The European Society of Cardiology
引用
收藏
页码:297 / 303
页数:7
相关论文
共 28 条
[1]
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease [J].
Ahmed, SH ;
Clark, LL ;
Pennington, WR ;
Webb, CS ;
Bonnema, DD ;
Leonardi, AH ;
McClure, CD ;
Spinale, FG ;
Zile, MR .
CIRCULATION, 2006, 113 (17) :2089-2096
[2]
Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload [J].
Chancey, AL ;
Brower, GL ;
Peterson, JT ;
Janicki, JS .
CIRCULATION, 2002, 105 (16) :1983-1988
[3]
Defects in matrix metalloproteinase inhibitory stoichiometry and selective MMP induction in patients with nonischemic or ischemic dilated cardiomyopathy [J].
Coker, ML ;
Zellner, JL ;
Crumbley, AJ ;
Spinale, FG .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC APPLICATIONS, 1999, 878 :559-562
[4]
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice [J].
Creemers, EEJM ;
Davis, JN ;
Parkhurst, AM ;
Leenders, P ;
Dowdy, KB ;
Hapke, E ;
Hauet, AM ;
Escobar, PG ;
Cleutjens, JPM ;
Smits, JFM ;
Daemen, MJAP ;
Zile, MR ;
Spinale, FG .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (01) :H364-H371
[5]
ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[6]
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure [J].
Heymans, S ;
Luttun, A ;
Nuyens, D ;
Theilmeier, G ;
Creemers, E ;
Moons, L ;
Dyspersin, GD ;
Cleutjens, JPM ;
Shipley, M ;
Angellilo, A ;
Levi, M ;
Nübe, O ;
Baker, A ;
Keshet, E ;
Lupu, F ;
Herbert, JM ;
Smits, JFM ;
Shapiro, SD ;
Baes, M ;
Borgers, M ;
Collen, D ;
Daemen, MJAP ;
Carmeliet, P .
NATURE MEDICINE, 1999, 5 (10) :1135-1142
[7]
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats [J].
Iwanaga, Y ;
Aoyama, T ;
Kihara, Y ;
Onozawa, Y ;
Yoneda, T ;
Sasayama, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (08) :1384-1391
[8]
Abnormalities of the extracellular degradation of collagen type I in essential hypertension [J].
Laviades, C ;
Varo, N ;
Fernández, J ;
Mayor, G ;
Gil, MJ ;
Monreal, I ;
Díez, J .
CIRCULATION, 1998, 98 (06) :535-540
[9]
Differential expression of tissue inhibitors of metalloproteinases in the failing human heart [J].
Li, YY ;
Feldman, AM ;
Sun, Y ;
McTiernan, CF .
CIRCULATION, 1998, 98 (17) :1728-1734
[10]
TIMP-1 - A marker of left ventricular diastolic dysfunction and fibrosis in hypertension [J].
Lindsay, MM ;
Maxwell, P ;
Dunn, FG .
HYPERTENSION, 2002, 40 (02) :136-141